Jing-Yuan Liu

Dr. Jing-Yuan Liu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2023 in Biology
Verified
Journal Article
Open access
PDF file
DGDeepti Gurung
Deepti Gurung
JDJacob Danielson
Jacob Danielson
ATAfsara Tasnim
Afsara Tasnim
JZJian-Ting Zhang
Jian-Ting Zhang
ZYZou Yue
Zou Yue
JLJing-Yuan Liu
Jing-Yuan Liu
Proline isomerization, the process of interconversion between the cis- and trans-forms of proline, is an important and unique post-translational modification that can affect protein folding and conformations, and ultimately regulate protein functions and biological pathways. Although impactful, the importance and prevalence of proline isomerization as a regulation mechanism in biological systems have not been fully understood or recognized. Aiming to fill gaps and bring new awareness, we attempt to provide a wholistic review on proline isomerization that firstly covers what proline isomerization is and the basic chemistry behind it. In this section, we vividly show that the cause of the unique ability of proline to adopt both cis- and trans-conformations in significant abundance is rooted from the steric hindrance of these two forms being similar, which is different from that in linear residues. We then discuss how proline isomerization was discovered historically followed by an introduction to all three types of proline isomerases and how proline isomerization plays a role in various cellular responses, such as cell cycle regulation, DNA damage repair, T-cell activation, and ion channel gating. We then explore various human diseases that have been linked to the dysregulation of proline isomerization. Finally, we wrap up with the current stage of various inhibitors developed to target proline isomerases as a strategy for therapeutic development.

1 July 2021 in Cancer Letters
Verified
Journal Article
Closed access
CWChao J. Wang
Chao J. Wang
DLDeren Li
Deren Li
JDJacob Danielson
Jacob Danielson
EZEvan H. Zhang
Evan H. Zhang
ZDZizheng Dong
Zizheng Dong
JLJing-Yuan Liu
Jing-Yuan Liu

1 March 2021 in Cancer Letters
Verified
Journal Article
Closed access
SMShi-Jie Ma
Shi-Jie Ma
ZDZizheng Dong
Zizheng Dong
Qingbin CuiQingbin Cui
Qingbin Cui
JLJing-Yuan Liu
Jing-Yuan Liu
JZJian-Ting Zhang
Jian-Ting Zhang

9 June 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RPRobert C. Peery
Robert C. Peery
KKKwaku Kyei-Baffour
Kwaku Kyei-Baffour
ZDZizheng Dong
Zizheng Dong
JLJianguo Liu
Jianguo Liu
PHPedro de Andrade Horn
Pedro de Andrade Horn
JZJian-Ting Zhang
Jian-Ting Zhang

28 April 2022 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
RPRobert Peery
Robert Peery
Qingbin CuiQingbin Cui
Qingbin Cui
KKKwaku Kyei-Baffour
Kwaku Kyei-Baffour
SJSophia Josephraj
Sophia Josephraj
CHCaoqinglong Huang
Caoqinglong Huang
JLJing-Yuan Liu
Jing-Yuan Liu

3 June 2022 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
HBHimadri Biswas
Himadri Biswas
SZShu-Jun Zhao
Shu-Jun Zhao
YMYetunde Makinwa
Yetunde Makinwa
JBJames S. Bassett
James S. Bassett
PMPhillip R. Musich
Phillip R. Musich
ZYZou Yue
Zou Yue
ATR is a PI3K-like kinase protein, regulating checkpoint responses to DNA damage and replication stress. Apart from its checkpoint function in the nucleus, ATR actively engages in an antiapoptotic role at mitochondria following DNA damage. The different functions of ATR in the nucleus and cytoplasm are carried out by two prolyl isomeric forms of ATR: trans- and cis-ATR, respectively. The isomerization occurs at the Pin1 Ser428-Pro429 motif of ATR. Here, we investigated the structural basis of the subcellular location-specific functions of human ATR. Using a mass spectrometry-based footprinting approach, the surface accessibility of ATR lysine residues to sulfo-NHS-LC-biotin modification was monitored and compared between the cis- and the trans-isomers. We have identified two biotin-modified lysine residues, K459 and K469, within the BH3-like domain of cis-ATR that were not accessible in trans-ATR, indicating a conformational change around the BH3 domain between cis- and trans-ATR. The conformational alteration also involved the N-terminal domain and the middle HEAT domain. Moreover, experimental results from an array of complementary assays show that cis-ATR with the accessible BH3 domain was able to bind to tBid while trans-ATR could not. In addition, both cis- and trans-ATR can directly form homodimers via their C-terminal domains without ATRIP, while nuclear (trans-ATR) in the presence of ATRIP forms dimer–dimer complexes involving both N- and C-termini of ATR and ATRIP after UV. Structural characteristics around the Ser428-Pro429 motif and the BH3 domain region are also analyzed by molecular modeling and dynamics simulation. In support, cis conformation was found to be significantly more energetically favorable than trans at the Ser428-Pro429 bond in a 20-aa wild-type ATR peptide. Taken together, our results suggest that the isomerization-induced structural changes of ATR define both its subcellular location and compartment-specific functions and play an essential role in promoting cell survival and DNA damage responses.